Alan Epstein
Gastroenterology · Providence, RINPI 1831157908
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,945 of the $35,501 with a category attached, or 70.3%. Gilead accounts for 80.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $13,872 and has fallen 99.2% since, to $105 in 2024. Among gastroenterology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $80.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$28K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$870
- Pfizer$627
- plus $1K from 12 others
Across 14 payments — averaging $1833.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$26K
What the payments were for
- Consulting fees$2901%
- Speaking & faculty fees$24,94570%
- Travel & lodging$2,1586%
- Food & beverage$8,05823%
- Gifts$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 59 | $28,456 |
| AbbVie(2 entities) | 107 | $1,991 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 62 | $1,099 |
| Takeda Pharmaceuticals U.S.A., Inc. | 57 | $1,060 |
| Johnson & Johnson | 43 | $870 |
| Pfizer | 46 | $627 |
| Nestle Healthcare Nutrition Inc. | 27 | $596 |
| Redhill Biopharma Inc. | 9 | $179 |
| Bristol Myers Squibb | 9 | $150 |
| Ironwood Pharmaceuticals, Inc | 6 | $126 |
| Braintree Laboratories, Inc. | 6 | $112 |
| Boston Scientific | 2 | $70 |
| Merck | 3 | $49 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Alfasigma USA, Inc. | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| QOL Medical, LLC | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$26,918
How this compares
$35,501 in reported general payments places this provider in the 90th percentile of 85 gastroenterology providers in Rhode Island.
Other gastroenterology in Providence
- Thomas SepeProvidence$307K
- Paul AkermanProvidence$123K
- Sean FineProvidence$55K
- Breton RousselProvidence$50K
- Samir ShahProvidence$28K
- Lisa MuellerProvidence$25K
- Nabil ToubiaProvidence$20K
- Thaer AbdelfattahProvidence$17K
- Eric NewtonProvidence$16K
- William ChenProvidence$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.